These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18692615)

  • 21. [The effectiveness of barrier methods of contraception with and without spermicide].
    Craig S; Hepburn S
    Contracept Fertil Sex (Paris); 1983 Oct; 11(10):1077-83. PubMed ID: 12339299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diaphragms in clinical trials: is clinician fitting necessary?
    Mauck C; Lai JJ; Schwartz J; Weiner DH
    Contraception; 2004 Apr; 69(4):263-6. PubMed ID: 15033398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring.
    Del Priore G; Malanowska-Stega J; Shalaby SW; Richman S
    J Reprod Med; 2009; 54(11-12):685-90. PubMed ID: 20120902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term acceptability of a single-size diaphragm among couples in South Africa and Thailand.
    Coffey PS; Kilbourne-Brook M; Beksinska M; Thongkrajai E
    J Fam Plann Reprod Health Care; 2008 Oct; 34(4):233-6. PubMed ID: 18854068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reappraisal of the postcoital test: a controlled study.
    Barnea ER; McInnes RD
    Int J Fertil; 1986; 31(1):46-9. PubMed ID: 2908275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Thurman AR; Moench TR; Hoke M; Politch JA; Cabral H; Mausser E; Nador E; Morton J; Hamorsky K; Swope K; Bratcher B; Anderson DJ; Whaley KJ
    Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaginal safety after use of a bioadhesive, acid-buffering, microbicidal contraceptive gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigao A; Souza MH; Mauck C; Waller D; Zaneveld L; Faundes A
    Contraception; 2006 May; 73(5):542-7. PubMed ID: 16627043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The postcoital test in the development of new vaginal contraceptives†.
    Mauck CK; Vincent KL
    Biol Reprod; 2020 Aug; 103(2):437-444. PubMed ID: 32657328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contraceptive efficacy of bioadhesive nonoxynol-9 Gel: comparison with nonoxynol-9 suppository].
    Xu JX; Shi LT; Zhou XB; Xiao ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):629-31. PubMed ID: 14728869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonoxynol-9 vaginal pessary: a preliminary Indian experience.
    Yadav SC; Gaur LN; Gupta N; Roy M; Saxena NC
    Natl Med J India; 2006; 19(3):133-6. PubMed ID: 16836262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential for revitalisation of the diaphragm for family planning in Uganda: a rapid assessment of the feasibility of introducing the SILCS Diaphragm.
    Kyamwanga IT; Turyakira E; Kilbourne-Brook M; Coffey PS
    Afr J Reprod Health; 2014 Jun; 18(2):77-86. PubMed ID: 25022144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.
    Pentlicky S; Rosen M; Coffey PS; Kilbourne-Brook M; Shaunik A; Schreiber CA; Barnhart K
    Contraception; 2013 Feb; 87(2):187-92. PubMed ID: 22898358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase I study of the functional performance, safety and acceptability of the BufferGel Duet.
    Ballagh SA; Brache V; Mauck C; Callahan MM; Cochon L; Wheeless A; Moench TR
    Contraception; 2008 Feb; 77(2):130-7. PubMed ID: 18226678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on nonoxynol-9 as vaginal spermicide.
    Iyer V; Poddar SS
    Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):339-50. PubMed ID: 19117251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Advantage 24 contraceptive gel claims 24-hour effectiveness. But proposed FDA rule could put N-9 products to the test.
    Contracept Technol Update; 1995 Apr; 16(4):45-9. PubMed ID: 12347026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diaphragm with and without spermicide. A randomized, comparative efficacy trial.
    Bounds W; Guillebaud J; Dominik R; Dalberth BT
    J Reprod Med; 1995 Nov; 40(11):764-74. PubMed ID: 8592310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compatibility between the spermicide nonoxynol 9 and mid-cycle human cervical mucus.
    Chantler E; Hemsworth M; Roach VP; Bruce JM
    Contraception; 1992 Sep; 46(3):289-95. PubMed ID: 1333387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I randomized safety study of a single-size silicone rubber diaphragm used with or without a lactic-acid-containing diaphragm gel.
    Thurman A; Cunningham T; Fichorova R; Herold BC; Hillier SL; Chandra N; Doncel GF
    Contraception; 2019 Dec; 100(6):430-437. PubMed ID: 31442441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncomparative contraceptive efficacy of cellulose sulfate gel.
    Mauck CK; Freziers RG; Walsh TL; Peacock K; Schwartz JL; Callahan MM
    Obstet Gynecol; 2008 Mar; 111(3):739-46. PubMed ID: 18310379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.